SANA — Sana Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Sana Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	551	424	205	152	138
Prepaid Expenses
Total Other Current Assets
Total Current Assets	558	444	214	161	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	162	159	146	135	65.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,129	823	565	501	417
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	99.2	112	64.5	45.4	78.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	401	323	278	251	256
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	729	499	288	251	161
Total Liabilities & Shareholders' Equity	1,129	823	565	501	417
Total Common Shares Outstanding